EUVIMEDEUVIMED entdecken
Crossref

Organ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours

Andrey G. Kriger, Stanislav V. Berelavichus, Ayrat R. Kaldarov, David S. Gorin, Marianna B. Raevskaya, Vladimir V. Kazennov, Vita Y. Zekster, Vladimir I. Panteleev

Surgical Practice · 2021-02 · 25 (1) · 4-9

DOI: 10.1111/1744-1633.12473 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Surgical Practice, online erschienen am 12.01.2021. Verfasst von Andrey G. Kriger und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Pancreatic neuroendocrine tumour (pNET) is a rare type of tumour with different malignant potential. Nowadays there is no universal approach for treatment of small and benign‐looking pNETs throughout the world.

Methods

There were 137 patients with pNETs surgically treated in our department between 2007 and 2017. Most of them were female ‐ 96 cases with median age 42 years old. Organ‐preserving procedures (OP) were performed in 44 (32%) cases and were compared with standard procedures 93 (68%) cases.

Results

Main intraoperative characteristics were comparable in groups. There was significantly less estimated blood loss volume in the OP group: less than 1 dL. Postoperative length of stay and drainage placement time were less in the OP group. There were less pancreatic fistulas and no delayed gastric empties in the OP group. 90‐day postoperative mortality rate was the same in both groups: four cases of severe postoperative pancreatitis with acute respiratory distress syndrome.

Conclusion

As the “wait‐and‐see” policy can be not useful due to uncontrolled disease progression, choice of organ‐preserving treatment first can become the first line of decision taking in small benign pNETs. Our experience shows that organ‐preserving treatment is more comfortable for the surgeon and for the patient. However, it is not the universal position. The long‐term survival data still has to be estimated.

Zitieren

APA

Kriger, A. G., Berelavichus, S. V., Kaldarov, A. R., Gorin, D. S., Raevskaya, M. B., Kazennov, V. V., Zekster, V. Y., & Panteleev, V. I. (2021). Organ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours. Surgical Practice, 25(1), 4-9. https://doi.org/10.1111/1744-1633.12473

Vancouver

Kriger AG, Berelavichus SV, Kaldarov AR, Gorin DS, Raevskaya MB, Kazennov VV, et al. Organ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours. Surgical Practice. 2021;25(1):4-9. doi:10.1111/1744-1633.12473

BibTeX
@article{Kriger2021,
  author = {Kriger, Andrey G. and Berelavichus, Stanislav V. and Kaldarov, Ayrat R. and Gorin, David S. and Raevskaya, Marianna B. and Kazennov, Vladimir V. and Zekster, Vita Y. and Panteleev, Vladimir I.},
  title = {Organ‐preserving procedures as an option for treatment of patients with pancreatic neuroendocrine tumours},
  journal = {Surgical Practice},
  year = {2021},
  volume = {25},
  number = {1},
  pages = {4--9},
  doi = {10.1111/1744-1633.12473}
}
Kostenlos starten →